Gender bias in drug dosage trials and overmedicated women

Article

A new study from the journal Biology of Sex Differences found an association between sex biases in drug dosage trials and the overmedication of women.

According to investigators, women are more likely than men to experience adverse drug reactions from medications, as clinical trials have historically focused on men.

In the August issue of Contemporary OB/GYN, Editor-in-Chief Dr. Catherine Y. Spong discussed the ways in which women’s health research has and continues to be marginalized. Read her full editorial here.

“Only in 1993, with the passage of the National Institutes of Health Revitalization Act, were women mandated to be included in NIH-funded research,” wrote Dr. Spong.

For additional details on the study’s findings, visit our sister publication, Drug Topics.

Recent Videos
Lisa Becht, MD, FACOG, sheds light on fertility awareness | Image Credit: havingbabies.com.
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Shayna Mancuso, DO, highlights the real impact of menopause | Image Credit: linkedin.com.
Jihong Liu, ScD, explains how to improve perinatal outcomes in COVID patients | Image Credit: sc.edu.
1 expert is featured in this series.
Jihong Liu, ScD, highlights adverse perinatal outcomes linked to the COVID pandemic | Image Credit: sc.edu.
Experts highlight infant health benefits from minor diet changes in pregnancy | Image Credit: ohsu.edu.
Related Content
© 2025 MJH Life Sciences

All rights reserved.